Abstract:Chemical modification is a precise and effective way to control the biogenesis, stability, and function of biological molecules, such as nucleic acids, proteins, and lipids. More than 170 different types of modifications have been discovered in coding and non-coding RNAs, constituting a diverse RNA modification landscape, called epitranscriptome. RNA modifications were mediated by three types of proteins: writers, erasers, and readers. Recently, RNA modification machinery has been dysregulated in several types of cancers and may be promising targets for cancer therapy. 3-methylcytidine (m3C), which is catalyzed by METTL2A, 2B, 6, and 8, is found at position 32 of cytoplasmic tRNAs in organisms ranging from yeast to humans, however, their functions and regulatory machinery in mRNA and non-coding RNA has not been clarified because there were no effective anti- m3C antibodies. Here we discovered that the expression of m3C writers was higher in pancreatic tumors than in noncancerous tissues. We further found that METTL2A expression is associated with a poor prognosis in pancreatic cancer patients. We also showed that METTL2A depletion led to a reduction in the growth of AsPC1 cells. We next attempted to identify the m3C sites in cellular transcripts regulated by METTL2A in AsPC1 cells using long-read direct RNA sequencing. We corrected the transcriptome using ESPRESSO and searched for the RNA modifications using Nanocompore. We then found that METTL2A targets the NYCYN motif in mRNAs and mitochondrial rRNAs. Moreover, we found that transcripts with METTL2A-mediated m3C modification were upregulated in AsPC-1 cells knocked down by METTL2A. Our study provides evidence for METTL2A-mediated down-regulation of target mRNAs via m3C modification in the survival of pancreatic tumor cells. Citation Format: Shuhei Mitsutomi, Anzu Sugawara, Kenji Takahashi, Yusuke Mizukami, Nobuyoshi Akimitsu, Kenzui Taniue. Identification of m3C modification sites within mRNAs of pancreatic cancer cells by long-read direct RNA sequencing [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2) nr B041.

AlkB Homologue 1 Demethylates N3-Methylcytidine in Mrna of Mammals

Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.

The Molecular Basis of Human ALKBH3 Mediated RNA N1‐methyladenosine (m1a) Demethylation

A METTL3–METTL14 Complex Mediates Mammalian Nuclear RNA N 6 -Adenosine Methylation

ALKBH5 is a Mammalian RNA Demethylase That Impacts RNA Metabolism and Mouse Fertility.

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

N 6 -Methyladenosine Modification-Mediated Mrna Metabolism is Essential for Human Pancreatic Lineage Specification and Islet Organogenesis

Demethylase-assisted site-specific detection of N1-methyladenosine in RNA

Novel Dual Methylation of Cytidines in the RNA of Mammals.

m3C32 tRNA modification controls serine codon-biased mRNA translation, cell cycle, and DNA-damage response

Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs

Formation and Determination of the Oxidation Products of 5-Methylcytosine in RNA

Abstract B041: Identification of m3C modification sites within mRNAs of pancreatic cancer cells by long-read direct RNA sequencing

N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation

N-6-Methyladenosine Methyltransferase ZCCHC4 Mediates Ribosomal RNA Methylation

ALKBH3-dependent M1a Demethylation of Aurora A Mrna Inhibits Ciliogenesis

Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition.

Structural and Functional Characterization of the Proteins Responsible for N(6)-Methyladenosine Modification and Recognition.

Structural Basis for METTL6-mediated M3c RNA Methylation.

RNA M1a Methylation Regulates Glycolysis of Cancer Cells Through Modulating ATP5D.

AlkB-Facilitated Demethylation Enables Quantitative and Site-Specific Detection of Dual Methylation of Adenosine in RNA.